Zofingen, Switzerland

Franz Radivojevich

This inventor holds 1 USPTO granted patent. Top assignee: Siegfried Aktiengesellschaft. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Franz Radivojevich. Retrieved from https://idiyas.com/inventor/franz-radivojevich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Franz Radivojevich: Innovator in Coronary Therapeutics

Introduction

Franz Radivojevich is a notable inventor based in Zofingen, Switzerland. He has made significant contributions to the field of coronary therapeutics, particularly through his innovative approach to drug formulation.

Latest Patents

Radivojevich holds a patent for a coronary therapeutic agent in the form of soft gelatin capsules. This invention addresses previous challenges related to capsule size and the low concentration of the active substance, nifedipine. By utilizing PVP and dissolving nifedipine in THFP, he has developed a formulation that allows for a capsule weight of only 162 mg.

Career Highlights

Radivojevich is associated with Siegfried Aktiengesellschaft, a company known for its focus on pharmaceutical development and manufacturing. His work has contributed to advancements in the delivery of coronary therapeutic agents.

Collaborations

He has collaborated with notable colleagues, including Stephan Dvorsky and Hans Joss, to further enhance the development of innovative therapeutic solutions.

Conclusion

Franz Radivojevich's contributions to coronary therapeutics exemplify the impact of innovation in the pharmaceutical industry. His patent for a soft gelatin capsule formulation represents a significant advancement in drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…